Company profile: PolyPeptide
1.1 - Company Overview
Company description
- Provider of contract manufacturing for peptides and peptide-related molecules with a global presence ensuring reliable supply. One of the world's largest independent contract manufacturers of therapeutic peptides, offering peptide and oligonucleotide API development and manufacturing, generic and cosmetic peptides, and green chemistry initiatives, including a production-scale solvent recovery system with Donaldson Company.
Products and services
- Generic Peptides: Produces a range of generic peptides for various applications, supported by worldwide operations enabling continuity of supply to clients with necessary capacity, contract-manufactured
- Oligonucleotide API Development and Manufacturing: Develops and produces oligonucleotide APIs for therapeutic products, leveraging a global presence to assure reliable supply and capacity for uninterrupted service across sites, API-grade
- Peptide API Development and Manufacturing: Architects and fabricates synthetic peptide APIs and intermediates for therapeutic products, applying green chemistry to reduce/recycle/replace/avoid hazardous solvents and production-scale solvent recovery purification, green chemistry-driven
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to PolyPeptide
Sterling Pharma Solutions
HQ: United Kingdom
Website
- Description: Provider of small molecule API development and manufacturing services for the global pharmaceutical industry, from pre-clinical to commercial. Offers ADC pre-clinical bioconjugation services with potent cytotoxin handling; PDMO® collaborative API development and integrated project management; hazardous chemistry; high potency and controlled substance API manufacturing; and peptide API development with large-scale chromatography.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Sterling Pharma Solutions company profile →
Pfanstiehl
HQ: United States
Website
- Description: Provider of cGMP-produced high-purity, injectable-grade excipients and bioprocessing solutions, specializing in isolation, purification, custom synthesis, and scale-up of regulated, low endotoxin injectable formulation ingredients, pharmaceutical intermediates, and APIs in gram to multi-ton quantities. Products include TRIS HCl, sodium gluconate, sucrose, trehalose, galactose, and L-arginine.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Pfanstiehl company profile →
PHMR
HQ: United Kingdom
Website
- Description: Provider of strategic consulting services to biopharmaceutical, diagnostics, MedTech, and life science companies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PHMR company profile →
Siegfried
HQ: Switzerland
Website
- Description: Provider of contract development and manufacturing for active pharmaceutical ingredients and drug products, including intermediates and controlled substances. Services span process development and optimization, formulation and pilot-scale production, registration support, and packaging and logistics for tablets, capsules, sterile vials, ampoules, cartridges, and ointments.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Siegfried company profile →
Vince & Associates
HQ: United States
Website
- Description: Provider of clinical research and cardiac safety services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Vince & Associates company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for PolyPeptide
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to PolyPeptide
2.2 - Growth funds investing in similar companies to PolyPeptide
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for PolyPeptide
4.2 - Public trading comparable groups for PolyPeptide
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →